Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

ABSTRACT: It is often challenging for the clinician interested in cystic fibrosis (CF) to interpret molecular genetic results, and to integrate them in the diagnostic process. The limitations of genotyping technology, the choice of mutations to be tested, and the clinical context in which the test is administered can all influence how genetic information is interpreted. This paper describes the conclusions of a consensus conference to address the use and interpretation of CF mutation analysis in clinical settings. Although the diagnosis of CF is usually straightforward, care needs to be exercised in the use and interpretation of genetic tests: genotype information is not the final arbiter of a clinical diagnosis of CF or CF transmembrane conductance regulator (CFTR) protein related disorders. The di

SUBMITTER: Castellani C 

PROVIDER: S-EPMC2810954 | biostudies-literature | 2008 May

REPOSITORIES: biostudies-literature